Collections

Filters ​

  • Collection |

    With this collection, Nature Communications, Nature Medicine, Communications Medicine and Scientific Reports aim to publish research articles spanning the breadth of AMR and across microbial pathogens (bacteria, viruses, fungi and parasites). This includes, and is not limited to epidemiological monitoring of resistance incidence in clinical and environmental settings, novel strategies aiming to combat or prevent AMR (i.e. drug repurposing, drug synergy treatment, and vaccines), improvements in diagnostics, and subsequently tailored treatment, of drug-resistant infections.

    Image: ©TopMicrobialStock / stock.adobe.com
    Open for submissions

  • Collection |

    With this Collection, a partnership between Nature, Nature Medicine and Nature Communications, we welcome submissions of primary research papers that focus on neo-adjuvant immunotherapies and related combinatorial approaches (such as radio-immunotherapy or chemo-immunotherapy).

    Image: wildpixel / Getty Images / iStock
    Open for submissions

  • Collection |

    Detailed method reporting is essential for research reproducibility and trust in published results.

    Image: Sam Whitham

  • Collection |

    The 2023 Nobel prize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their “discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”.

    Image: Springer Nature/The Nobel Foundation/Imagesource

  • Collection |

    The year 2023 marks the mid-point of the 15-year period envisaged to achieve the Sustainable Development Goals, targets for global development adopted in September 2015 by all United Nations Member States.

    Image: © Springer Nature
    Open for submissions

  • Collection |

    Stem cell models of development, regeneration, and disease are quickly advancing. New technologies and concepts are continuously combined with existing knowledge to create more realistic systems to improve our understanding of these intricate processes. In this collection, we highlight papers published in 2022-2023 across Nature Portfolio journals on topics including embryonic development and stem cells, reproductive biology, synthetic tissues and embryo models, clinical and translational research and tissue stem cells.

    Image: Jean-Baptiste Sibarita, Virgile Viasnoff, and Anne Beghin

  • Collection |

    Cancer is a leading cause of death, accounting for nearly one in six deaths worldwide. Many cancers can be cured, especially if detected early and treated effectively.

    Image: Kateryna Lon/ Science Photo Library/ Getty Images

  • Collection |

    Following the recent declaration from the World Health Organization that the ongoing monkeypox (now named mpox) outbreak is a Public Health Emergency of International Concern, the editorial teams at Nature Portfolio have curated a collection of relevant articles.

    Image: NIAID

  • Collection |

    The Burden of Proof Studies from the Institute of Health Metrics and Evaluation provide a new method for assessing the cumulative strength of available evidence for risk factors and associated health outcomes.

    Image: Annika Newell

  • Collection |

    The 2022 Nobel Prize in Chemistry has been awarded to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless for the development of click chemistry and bioorthogonal chemistry.

    Image: Springer Nature/The Nobel Foundation/Imagesource

  • Collection |

    Recent technological progress has facilitated the study of how embryos develop, how embryonic cells transition between different states, how adult stem cells are maintained and differentiate, at unprecedented resolution.

    Image: Deepti L Kumar and Tony DeFalco

  • Collection |

    This collection of research, review and comment from Nature Research celebrates the 2020 Nobel Prize in Physiology or Medicine awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice "for the discovery of hepatitis C virus".

    Image: Springer Nature/The Nobel Foundation/Imagesource